KIRASTEN BRASFIELD

Allopathic & Osteopathic Physicians|Family Medicine CHATSWORTH, GA NPI 1861998460

General Payments — all program years on this page

$2,776.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 178
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $362.04 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $362.0419

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $156.329
Novo Nordisk AS $135.086
Astellas Pharma US Inc $21.661
SHIELD THERAPEUTICS INC $17.211
Amgen Inc. $17.081
Lilly USA, LLC $14.691

By program year

Program yearAmountRecords
2018 $11.491
2019 $14.691
2021 $274.2517
2022 $1,336.2687
2023 $777.5353
2024 $362.0419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096613438 Novo Nordisk Inc $24.31 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096926450 Novo Nordisk Inc $24.63 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096939187 Novo Nordisk Inc $21.16 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096963091 Novo Nordisk Inc $21.92 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097087074 Novo Nordisk Inc $23.73 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097103508 Novo Nordisk Inc $19.33 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363375 ABBVIE INC. $7.99 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363377 ABBVIE INC. $31.46 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363379 ABBVIE INC. $15.46 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363381 ABBVIE INC. $32.83 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363383 ABBVIE INC. $1.55 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363385 ABBVIE INC. $9.19 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363387 ABBVIE INC. $7.70 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363389 ABBVIE INC. $20.34 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103363391 ABBVIE INC. $29.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111535789 Amgen Inc. $17.08 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135109046 Lilly USA, LLC $14.69 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139383418 Astellas Pharma US Inc $21.66 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150144962 SHIELD THERAPEUTICS INC $17.21 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.